Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Daniella Dias-Santos"'
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Complete results for GO (Supplementary Table 8) and REACTOME (supplementary Table 9) analysis on differentially expressed genes comparing lisinopril vs. control PDAC tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a97412331ed48f091bd5cfe1c4de9fb
https://doi.org/10.1158/1078-0432.22466741.v1
https://doi.org/10.1158/1078-0432.22466741.v1
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Adjusted Analysis with Multivariate Model on TCGA PDAC dataset to test for independent factors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d36d5b62a78044cfd16f50e6e6e96bc
https://doi.org/10.1158/1078-0432.22466750
https://doi.org/10.1158/1078-0432.22466750
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Purpose: Angiotensin system inhibitors (ASI) can improve prognosis in multiple cancer types, including pancreatic ductal adenocarcinoma (PDAC). However, no study has examined the effect of ASIs alone or combined with adjuvant chemotherapy in resected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5de36c154c181faa8284778e34dfd1
https://doi.org/10.1158/1078-0432.c.6526415.v1
https://doi.org/10.1158/1078-0432.c.6526415.v1
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Patient characteristics, unadjusted univariate model and adjusted analysis with multivariate model analyses in metastatic patients (supplementary table 1) and locally advanced patients (supplementary table 2) Supplementary Table 3: Unadjusted Univari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235adebf1281395bcf090a0e4d89bb15
https://doi.org/10.1158/1078-0432.22466759
https://doi.org/10.1158/1078-0432.22466759
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Supplementary table and figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::017e10a0fa8c622adf2c1e933453d86b
https://doi.org/10.1158/1078-0432.22466738
https://doi.org/10.1158/1078-0432.22466738
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Genes differentially expressed in ACEi alone treated group compared to control group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5c24328e783a028078f0649ae1c15c1
https://doi.org/10.1158/1078-0432.22466747
https://doi.org/10.1158/1078-0432.22466747
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Selected key pathways up-regulated or down-regulated by ACEi treatment alone in Gene Set Enrichment Analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::246b670a1d915fe3fe40a8fed6516516
https://doi.org/10.1158/1078-0432.22466756.v1
https://doi.org/10.1158/1078-0432.22466756.v1
Autor:
Rakesh K. Jain, Yves Boucher, Cristina R. Ferrone, James Michaelson, Ronald M. Evans, Michael Downes, Carlos Fernandez-del Castillo, Keith D. Lillemoe, Vikram Deshpande, David P. Ryan, Janet E. Murphy, Jeffrey W. Clark, Theodore S. Hong, Andrea Zanconato, Daniella Dias-Santos, Theodoros Michelakos, Alex Jacobson, Jonathan A. Crain, William W. Ho, Kohei Shigeta, Hang Lee, Joao Incio, Matthias Pinter, Kamila Naxerova, Hao Liu
Supplementary Figure 1: Clinical status of patients included in the analysis Supplementary Figure 2: Unadjusted Kaplan Meier survival curves of patients who received ACEi (green), ARB (yellow) vs. control group (blue). Supplementary Figure 3: Chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d1fe0e392d9548ff06382ebc7c33df
https://doi.org/10.1158/1078-0432.22466762
https://doi.org/10.1158/1078-0432.22466762
Autor:
Ronald M. Evans, Andrea Zanconato, Joao Incio, Jonathan Crain, Daniella Dias-Santos, Vikram Deshpande, Carlos Fernandez-del Castillo, Hang Lee, Jeffrey W. Clark, A. Jacobson, Kamila Naxerova, Kohei Shigeta, Janet E. Murphy, James S. Michaelson, David P. Ryan, Keith D. Lillemoe, William Ho, Michael Downes, Yves Boucher, Theodoros Michelakos, Matthias Pinter, Rakesh K. Jain, Cristina R. Ferrone, Hao Liu, Theodore S. Hong
Purpose: Angiotensin system inhibitors (ASI) can improve prognosis in multiple cancer types, including pancreatic ductal adenocarcinoma (PDAC). However, no study has examined the effect of ASIs alone or combined with adjuvant chemotherapy in resected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1b52b0d114bba455eb3c450029dd4c
https://europepmc.org/articles/PMC5856249/
https://europepmc.org/articles/PMC5856249/
Autor:
A. Jacobson, Hang Lee, Keith D. Lillemoe, Kamila Naxerova, Vikram Deshpande, Hao Liu, James S. Michaelson, Michael Downes, Yves Boucher, Matthias Pinter, Carlos Fernandez del Castillos, Jonathan Crain, Joao Incio, Andrea Zanconato, Mengyang Di, Ronald M. Evans, Cristina R. Ferrone, Daniella Dias Santos, Jain K. Rakesh, William Ho
Publikováno v:
Cancer Research. 77:957-957
Introduction: Angiotensin system inhibitors (ASI) are widely used to manage hypertension. Laboratory and retrospective clinical data suggests that ASIs can improve cancer prognosis. The aim of this study is to investigate the effect of ASIs on overal